2019-10-07 Conversion | 2019-10-07 7:40 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,993,658 | $0 | 2,006,328 (Indirect) | View |
2019-10-07 Conversion | 2019-10-07 7:40 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 512,995 | $0 | 2,519,323 (Indirect) | View |
2019-10-07 Conversion | 2019-10-07 7:40 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,993,658 | $0 | 0 (Indirect) | View |
2019-10-07 Conversion | 2019-10-07 7:40 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 512,995 | $0 | 0 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 10,420 | $0 | 12,438 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,654,359 | $0 | 1,974,798 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,941,500 | $0 | 1,941,500 (Direct) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 495,388 | $0 | 2,436,888 (Direct) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 566,158 | $0 | 566,158 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 10,420 | $0 | 0 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,654,359 | $0 | 0 (Indirect) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,941,500 | $0 | 0 (Direct) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 495,388 | $0 | 0 (Direct) | View |
2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 566,158 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,973,787 | $0 | 5,305,372 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 380,817 | $0 | 380,817 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,277,111 | $0 | 1,277,111 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 653,412 | $0 | 5,958,784 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 150,085 | $0 | 530,902 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 503,327 | $0 | 1,780,438 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 454,548 | $0 | 6,413,332 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 104,407 | $0 | 635,309 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 350,141 | $0 | 2,130,579 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 810,522 | $0 | 810,522 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 15,000,000 | $0 | 0 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,148,474 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,851,526 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,970,572 | $0 | 0 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 452,630 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,517,940 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,370,833 | $0 | 0 (Direct) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 314,873 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,055,960 | $0 | 0 (Indirect) | View |
2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 2,444,382 | $0 | 0 (Indirect) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 2,977,242 (Direct) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 4,026,417 (Direct) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 708,352 (Indirect) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 0 (Direct) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 0 (Direct) | View |
2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 0 (Indirect) | View |
2020-05-18 Other | 2020-05-20 9:58 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 116,664 | $0 | 216,669 (Direct) | View |
2020-05-18 Other | 2020-05-20 9:58 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,750 | $0 | 1,750 (Indirect) | View |
2020-05-18 Other | 2020-05-20 9:58 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,750 | $0 | 0 (Indirect) | View |
2020-05-18 Other | 2020-05-20 9:58 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,734 | $0 | 1,734 (Indirect) | View |
2020-05-18 Other | 2020-05-20 9:58 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,734 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2,054,198 | $0 | 2,705,660 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 156,335 | $0 | 205,915 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 68,398 | $0 | 90,090 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 61,791 | $0 | 81,387 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2,443,883 | $0 | 2,443,883 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 111,361 | $0 | 2,817,021 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 8,475 | $0 | 214,390 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,708 | $0 | 93,798 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,350 | $0 | 84,737 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 875,568 | $0 | 3,319,451 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 458,282 | $0 | 458,282 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2,054,198 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 156,335 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 68,398 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 61,791 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2,443,883 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 111,361 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 8,475 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,708 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,350 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 875,568 | $0 | 0 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 7:40 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 458,282 | $0 | 0 (Indirect) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,176,507 | $0 | 3,176,507 (Direct) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 577,544 | $0 | 577,544 (Indirect) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 14,452,795 | $0 | 0 (Direct) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,745,458 | $0 | 0 (Direct) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,245,330 | $0 | 0 (Indirect) | View |
2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 333,333 | $0 | 0 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 192,576 | $0 | 2,017,016 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,033 | $0 | 1,033 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 57,424 | $0 | 601,445 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,098 | $0 | 4,131 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,131 | $0 | 0 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 79,217 | $0 | 1,127,386 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,187 | $0 | 1,187 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,187 | $0 | 0 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,177 | $0 | 1,177 (Indirect) | View |
2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,177 | $0 | 0 (Indirect) | View |
2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 300,000 | $0 | 6,497,230 (Direct) | View |
2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,000 | $0 | 6,000 (Indirect) | View |
2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,000 | $0 | 0 (Indirect) | View |
2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 5,176 | $0 | 5,176 (Indirect) | View |
2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 5,176 | $0 | 0 (Indirect) | View |
2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 300,000 | $0 | 6,197,230 (Direct) | View |
2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,000 | $0 | 6,000 (Indirect) | View |
2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,000 | $0 | 0 (Indirect) | View |
2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 5,176 | $0 | 5,176 (Indirect) | View |
2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 5,176 | $0 | 0 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 400,000 | $0 | 5,797,230 (Direct) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,000 | $0 | 8,000 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,000 | $0 | 0 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,901 | $0 | 6,901 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,901 | $0 | 0 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 79,216 | $0 | 1,046,562 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,187 | $0 | 1,187 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,187 | $0 | 0 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,177 | $0 | 1,177 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,177 | $0 | 0 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 192,576 | $0 | 1,824,440 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,033 | $0 | 1,033 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 57,424 | $0 | 544,021 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,098 | $0 | 4,131 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,131 | $0 | 0 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 39,608 | $0 | 1,001,598 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 593 | $0 | 593 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 593 | $0 | 0 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 588 | $0 | 588 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 588 | $0 | 0 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 192,576 | $0 | 1,631,864 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,033 | $0 | 1,033 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 57,424 | $0 | 486,597 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,098 | $0 | 4,131 (Indirect) | View |
2020-10-06 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,131 | $0 | 0 (Indirect) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 2,145,991 | $0 | 2,145,991 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,839 | $0 | 2,344,830 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 85,065 | $0 | 2,429,895 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 463,959 | $0 | 463,959 (Indirect) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,485 | $0 | 662,444 (Indirect) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 2,145,991 | $0 | 0 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,839 | $0 | 0 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 463,959 | $0 | 0 (Indirect) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 85,065 | $0 | 0 (Direct) | View |
2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,485 | $0 | 0 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 690,814 | $0 | 4,955,563 (Direct) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 13,816 | $0 | 13,816 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 13,816 | $0 | 0 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 11,918 | $0 | 11,918 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 11,918 | $0 | 0 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 199,652 | $0 | 1,432,212 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,071 | $0 | 1,071 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 59,534 | $0 | 427,063 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,211 | $0 | 4,282 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,282 | $0 | 0 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 476,659 | $0 | 4,341,941 (Direct) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 9,533 | $0 | 9,533 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 9,533 | $0 | 0 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,223 | $0 | 8,223 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,223 | $0 | 0 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 84,462 | $0 | 884,492 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,269 | $0 | 1,269 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,269 | $0 | 0 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,258 | $0 | 1,258 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 1,258 | $0 | 0 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 154,671 | $0 | 1,277,541 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 828 | $0 | 828 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 46,121 | $0 | 380,942 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 2,488 | $0 | 3,316 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 3,316 | $0 | 0 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 394,000 | $0 | 3,947,941 (Direct) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 7,880 | $0 | 7,880 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 7,880 | $0 | 0 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,797 | $0 | 6,797 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 6,797 | $0 | 0 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 31,175 | $0 | 842,924 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 467 | $0 | 467 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 467 | $0 | 0 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 463 | $0 | 463 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 463 | $0 | 0 (Indirect) | View |
2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 20,784 | $0 | 822,140 (Indirect) | View |
2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 310 | $0 | 310 (Indirect) | View |
2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 310 | $0 | 0 (Indirect) | View |
2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 307 | $0 | 307 (Indirect) | View |
2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 307 | $0 | 0 (Indirect) | View |
2020-12-15 Other | 2020-12-17 9:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 285,217 | $0 | 2,531,804 (Indirect) | View |
2020-12-15 Other | 2020-12-17 9:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 8,579 | $0 | 76,158 (Indirect) | View |
2020-12-15 Other | 2020-12-17 9:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 9,497 | $0 | 84,301 (Indirect) | View |
2020-12-15 Other | 2020-12-17 9:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 21,707 | $0 | 192,683 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 153,579 | $0 | 2,378,225 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 33,173 | $0 | 33,173 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,620 | $0 | 71,538 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 998 | $0 | 34,171 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,113 | $0 | 79,188 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,105 | $0 | 35,276 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 35,276 | $0 | 0 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 11,688 | $0 | 180,995 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,388 | $0 | 1,388 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,388 | $0 | 0 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 275,000 | $0 | 3,144,451 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,500 | $0 | 5,500 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,500 | $0 | 0 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,744 | $0 | 4,744 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,744 | $0 | 0 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 50,000 | $0 | 558,282 (Direct) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 751 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 0 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 745 (Indirect) | View |
2021-01-14 Other | 2021-01-19 8:17 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 263,278 | $0 | 2,114,947 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 56,868 | $0 | 56,868 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 7,919 | $0 | 63,619 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,711 | $0 | 58,579 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 8,766 | $0 | 70,422 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,893 | $0 | 60,472 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 60,472 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 20,037 | $0 | 160,958 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,328 | $0 | 4,328 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,328 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 250,000 | $0 | 2,894,451 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,000 | $0 | 5,000 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,000 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,313 | $0 | 4,313 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 4,313 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 50,000 | $0 | 508,282 (Direct) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 751 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 0 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 745 (Indirect) | View |
2021-01-29 Other | 2021-02-02 6:43 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 0 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 300,000 | $0 | 2,594,451 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 6,000 | $0 | 6,000 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 6,000 | $0 | 0 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,176 | $0 | 5,176 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 5,176 | $0 | 0 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 50,000 | $0 | 458,282 (Direct) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 751 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 751 | $0 | 0 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 745 (Indirect) | View |
2021-02-16 Other | 2021-02-18 5:13 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 745 | $0 | 0 (Indirect) | View |
2021-02-17 Other | 2021-02-19 5:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 325,000 | $0 | 2,236,888 (Direct) | View |
2021-02-17 Other | 2021-02-19 5:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 6,500 | $0 | 6,500 (Indirect) | View |
2021-02-17 Other | 2021-02-19 5:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 6,500 | $0 | 0 (Indirect) | View |
2021-02-17 Other | 2021-02-19 5:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 5,607 | $0 | 5,607 (Indirect) | View |
2021-02-17 Other | 2021-02-19 5:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 5,607 | $0 | 0 (Indirect) | View |
2021-03-26 Other | 2021-03-30 7:05 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 320,368 | $0 | 1,681,930 (Indirect) | View |
2021-03-26 Other | 2021-03-30 7:05 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 82,491 | $0 | 82,491 (Indirect) | View |
2021-03-26 Other | 2021-03-30 7:05 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 82,491 | $0 | 0 (Indirect) | View |
2021-03-26 Other | 2021-03-30 7:05 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,990 | $0 | 10,448 (Indirect) | View |